Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human MT3 ELISA Kit (AC2551)
Cat.#: ASET-1140
Specifications
Description Human MT3 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human MT3 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.023 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.4-6.4 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1138 Human LUZP1 ELISA Kit (AC2549) Quantitative inquiry ASET-1750 Human alpha Synuclein ELISA Kit (AC3161) Quantitative inquiry ASET-1643 Human GALC ELISA Kit (AC3054) Quantitative inquiry ASET-2073 Human P2Y2 ELISA Kit (AC3484) Quantitative inquiry ASET-1796 Human iNOS ELISA Kit (AC3207) Quantitative inquiry ASET-2186 Human Calretinin ELISA Kit (AC3597) Quantitative inquiry ASET-2170 Rat Dopamine Receptor D1 ELISA Kit (AC3581) Quantitative inquiry ASET-2543 Human Neuropilin 1 ELISA Kit (AC3954) Quantitative inquiry ASET-1967 Human Estrogen Receptor beta ELISA Kit (AC3378) Quantitative inquiry ASET-1712 Human GnRHR ELISA Kit (AC3123) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket